CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)	3 Months Ended		12 Months Ended	147 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Mar. 31, 2024
Cash flows from operating activities
Net increase in net assets resulting from operations	$ 13,148,460	$ 4,736,147
Adjustments to reconcile net increase in net assets from operations to net cash used in operating activities:
Purchases of investments	(28,516,430)	(41,237,273)
Proceeds from sales and repayments of investments	31,169,595	5,890,813
Net change in unrealized (appreciation) depreciation on investments	(23,518,590)	4,249,642
Net change in unrealized depreciation on foreign currency translations	3,602	10,126
Increase in investments due to PIK	(750,054)	(769,954)
Amortization of premium and accretion of discount, net	(702,543)	(665,998)	$ (2,749,543)
Deferred tax provision	192,607	78,760
Amortization of loan structure fees	264,707	143,822
Amortization of deferred financing costs	111,374	110,150
Amortization of loan fees on SBA-guaranteed debentures	314,055	317,508
Net realized loss (gain) on investments	20,384,731	(34,967)
Changes in other assets and liabilities
Increase in interest receivable	(1,602,062)	(187,420)
Increase in income tax receivable	(1,085,022)
Decrease in prepaid expenses	21,256	148,414
Decrease in management fees payable	(1,066,303)	(2,592,566)
(Decrease) increase in income incentive fees payable	(140,107)	2,124,835
Decrease in capital gains incentive fees payable		(569,528)
Increase in administrative services payable	22,897	39,951
Decrease in interest payable	(3,748,120)	(3,437,073)
Decrease in related party payable		(646,393)
Increase (decrease) in unearned revenue	14,589	(47,573)
Increase in income tax payable		374,460
Decrease in other accrued expenses and liabilities	(61,688)	(78,907)
Net Cash Provided (Used) in Operating Activities	4,456,954	(32,043,024)
Cash flows from Financing Activities
Proceeds from the issuance of common stock		8,487,127		$ 341,650,411
Sales load for common stock issued		(126,303)
Offering costs paid for common stock issued	(5,209)	(72,955)
Stockholder distributions paid	(6,431,896)	(5,252,174)
Financing costs paid on Credit Facility	(49,969)
Borrowings under Credit Facility	50,000,000	13,300,000
Repayments of Credit Facility	(25,333,900)	(14,483,900)
Net Cash Provided by Financing Activities	18,179,026	1,851,795
Net Increase (Decrease) in Cash and Cash Equivalents	22,635,980	(30,191,229)
Cash and Cash Equivalents Balance at Beginning of Period	26,125,741	48,043,329	48,043,329
Cash and Cash Equivalents Balance at End of Period	48,761,721	17,852,100	$ 26,125,741	$ 48,761,721
Supplemental and Non-Cash Activities
Cash paid for interest expense	10,825,557	10,752,017
Income and excise tax paid	1,455,741	303
Increase in distributions payable	3,215,948	2,699,110
Increase in deferred offering costs	5,209	$ 2,700
Exchange of investments	$ 8,256,411